{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:29:56Z","timestamp":1791350996059,"version":"4.3.1"},"reference-count":135,"publisher":"Baishideng Publishing Group Inc.","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3748\/wjg.v22.i28.6345","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T05:10:31Z","timestamp":1469509831000},"page":"6345","source":"Crossref","is-referenced-by-count":115,"title":["Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer"],"prefix":"10.3748","volume":"22","author":[{"given":"Vincenzo","family":"Sforza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato","family":"Ciardiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Gambardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carminia","family":"della Corte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cardone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna L","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Reginelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Belli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Troiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21262"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds236"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu260"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414325"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/35052073"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1609"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0707704"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.03992.x"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70118-4"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033025"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.1620"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0462"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2014.06.005"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nature12625"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.037"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu378"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70130-3"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0558"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0109"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2609"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Arena S, Bellosillo B, Siravegna G, Mart&iacute;nez A, Ca\u00f1adas I, Lazzari L, Ferruz N, Russo M, Misale S, Gonz&aacute;lez I. Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer. Clin Cancer Res 2015;21:2157-2166.","DOI":"10.1158\/1078-0432.CCR-14-2821"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007094"},{"key":"ref23","unstructured":"Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989;49:4682-4689."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2008-0181"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0191"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804385"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.7116"},{"key":"ref28","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use. May 2008 Plenary Meeting Monthly Report. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.emea.europa.eu\/pdfs\/human\/press\/pr\/27923508en.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.emea.europa.eu\/pdfs\/human\/press\/pr\/27923508en.pdf<\/ext-link>."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.4860"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.6055"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.5091"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1305275"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.2473"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70330-4"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.4812"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.04.007"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu230"},{"key":"ref38","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000558\/WC500160158.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000558\/WC500160158.pdf<\/ext-link>."},{"key":"ref39","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000741\/WC500148667.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000741\/WC500148667.pdf<\/ext-link>."},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/nature11219"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/nature11156"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007947"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28106"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1535"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.2592"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.11.025"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv385"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.6843"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv176"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1038\/nm0895-792"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-005-2908-y"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Migliardi G, Sassi F, Torti D, Galimi F, Zanella ER, Buscarino M, Ribero D, Muratore A, Massucco P, Pisacane A. Inhibition of MEK and PI3K\/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas. Clin Cancer Res 2012;18:2515-2525.","DOI":"10.1158\/1078-0432.CCR-11-2683"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154007"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1038\/nature12796"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Ziemke EK, Dosch JS, Maust JD, Shettigar A, Sen A, Welling TH, Hardiman KM, Sebolt-Leopold JS. Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy That Cotargets MEK and CDK4\/6. Clin Cancer Res 2016;22:405-414.","DOI":"10.1158\/1078-0432.CCR-15-0829"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-051513-102539"},{"key":"ref57","unstructured":"ClinicalTrials. gov Identifier: NCT01274624. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">https:\/\/clinicaltrials.gov\/<\/ext-link>."},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-04-0297"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1038\/nature00766"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1038\/418934a"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.02.057"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.0786"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.6796"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70163-3"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq632"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.01.054"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.2497"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1038\/nature10868"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1446"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.2471"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2779"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432"},{"key":"ref73","unstructured":"ClinicalTrials. gov Identifier: NCT01750918; NCT01719380. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">https:\/\/clinicaltrials.gov\/<\/ext-link>."},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-1518"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu193.7"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70209-6"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1126\/science.1150799"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602970"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5659"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2466"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr464"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2014.40728"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2410"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.6544"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.02.141"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604009"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.2796"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0606"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1038\/nature11252"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37539"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4204"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-014-0177-3"},{"key":"ref93","unstructured":"ClinicalTrials. gov Identifier: NCT01139138. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">https:\/\/clinicaltrials.gov\/<\/ext-link>."},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1080\/07357900802314893"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160922976"},{"key":"ref96","unstructured":"ClinicalTrials. gov Identifier: NCT01363232; NCT01449058. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">https:\/\/clinicaltrials.gov\/<\/ext-link>."},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1207756"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1537685100"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002442"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00150-9"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0119"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.04.012"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.09.003"},{"key":"ref104","doi-asserted-by":"crossref","unstructured":"Cervantes-Ruiperez A, Juric D, Hidalgo M, Messersmith WA, Blumenschein GR, Baselga J, Perez DR, Dienstmann R, Calles A, Jimeno A. A phase I study of MEHD7945A (MEHD), a first-in-class HER3\/EGFR dual-action antibody, in patients (pts) with refractory\/recurrent epithelial tumors: expansion cohorts. J Clin Oncol 2012;30 Suppl:abstract 2568.","DOI":"10.1200\/jco.2012.30.15_suppl.2568"},{"key":"ref105","unstructured":"Presented at AACR Annual Meeting, April 18-21, 2015, Philadelphia, PA. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/qfuse.com\/client_downloads\/AACR2015_DARECK_poster_15Apr15.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/qfuse.com\/client_downloads\/AACR2015_DARECK_poster_15Apr15.pdf<\/ext-link>."},{"key":"ref106","doi-asserted-by":"crossref","unstructured":"Price TJ, Newhall J, Peeters M. Prevalence and outcomes of patients (pts) with EGFR S492R ectodomain mutations in ASPECCT: Panitumumab (pmab) vs. cetuximab (cmab) in pts with chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer (mCRC). J Clin Oncol 2015;33 Suppl 3:abstract 740.","DOI":"10.1200\/jco.2015.33.3_suppl.740"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1417"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-1432"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-14-0772"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2530"},{"key":"ref111","unstructured":"Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L, Nordlinger B, Bretti S, Bottardi S, Giordano S. Overexpression and amplification of the met\/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1995;1:147-154."},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i12.3706"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604439"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0423"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2752"},{"key":"ref116","unstructured":"ClinicalTrials. gov Identifier: NCT02008383. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">https:\/\/clinicaltrials.gov\/<\/ext-link>."},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808268"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.8135"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.0543"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-3058"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3389"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4765"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2181"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0020"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0452"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.3816\/CCC.2010.n.046"},{"key":"ref127","unstructured":"ClinicalTrials. gov Identifier: NCT02296203; NCT02316496. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">https:\/\/clinicaltrials.gov\/<\/ext-link>."},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw136"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.8888"},{"key":"ref130","doi-asserted-by":"crossref","unstructured":"Bridgewater JA, Cervantes A, Markman B, Siena S, Cubillo A, Carbonero RG, Sigal D, Aprile G, Cunningham D, Nadal C. GAIN-(C): Efficacy and safety analysis of imgatuzumab (GA201), a novel dual-acting monoclonal antibody (mAb) designed to enhance antibody-dependent cellular cytotoxicity (ADCC), in combination with FOLFIRI compared to cetuximab plus FOLFIRI in second-line KRAS exon 2 wild type (e2WT) or with FOLFIRI alone in mutated (e2MT) metastatic colorectal cancer (mCRC). J Clin Oncol 2015;33 Suppl:abstr 669.","DOI":"10.1200\/jco.2015.33.3_suppl.669"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500596"},{"key":"ref132","unstructured":"ClinicalTrials. gov Identifier: NCT02298946; NCT01375842; NCT02335918; NCT01633970; NCT01772004; NCT02227667. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">https:\/\/clinicaltrials.gov\/<\/ext-link>."},{"key":"ref133","doi-asserted-by":"crossref","unstructured":"Perez EA, Thompson EA, Ballman KV, Anderson SK, Asmann YW, Kalari KR, Eckel-Passow JE, Dueck AC, Tenner KS, Jen J. Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial. J Clin Oncol 2015;33:701-708.","DOI":"10.1200\/JCO.2014.57.6298"},{"key":"ref134","unstructured":"ClinicalTrials. gov Identifier: NCT01309126; NCT02318901. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">https:\/\/clinicaltrials.gov\/<\/ext-link>."},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1038\/nature12065"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i28\/6345.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T05:23:54Z","timestamp":1600925034000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i28\/6345.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":135,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v22.i28.6345","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}